Central Garden & Pet: Margin Expansion And Guidance Hike Prove The Distribution Exit Was Worth It

Central Garden & Pet raised its full-year earnings guidance after a quarter that looked like a step back on top-line sales but was really a step forward in margin quality. I'm rating the stock a Buy: the pet distribution exit has structurally improved profitability, the company is generating strong cash, and the valuation still gives room for error on a pending European acquisition that could be transformative.

What The Market Got Wrong About Q3

Reported net sales fell 8% to $882 million. That headline is misleading because it includes the drag from exiting the pet distribution business at the beginning of the quarter. On an organic basis, sales grew 2% to $862 million. Management spun up a joint venture with Phillips Pet Food & Supplies in April to absorb the distribution operations, swapping a thin-margin logistics business for a cleaner, higher-margin consumer-goods profile.

The evidence that the move was the right one shows up in margins. Gross margin expanded 130 basis points to 35.9%. Adjusted EBITDA - earnings before interest, taxes, depreciation, and amortization, a rough proxy for cash earnings power - margin rose a full 100 basis points to 18.3%, even as EBITDA dollars ticked down slightly to $162 million from $167 million. Operating cash flow for the quarter hit a record $327 million, up from $265 million a year ago, driven by seasonal working capital swings. That kind of cash generation matters because it funds the next phase of the story without stretching the balance sheet.

The Pet Segment Is The Key

The pet business is where the distribution exit shows the clearest before-and-after picture. Reported Pet segment sales dropped 19% to $400 million, but organic sales grew 2% to $380 million. More important, non-GAAP operating margin jumped 320 basis points to 19.0% from 15.8%. Adjusted EBITDA margin expanded 350 basis points to 21.4%.

That margin expansion isn't cosmetic. The pet distribution business was a volume-heavy, low-margin operation. Stripping it out leaves a branded pet company - Nylabone, Kaytee, Aqueon, Comfort Zone - with pricing power and direct channel relationships. The 2% organic growth is modest, but the margin profile is now the kind that justifies a higher multiple if growth accelerates.

The Garden segment held up nicely. Sales grew 3% to $482 million, driven by Wild Bird, Fertilizer and Controls, and Grass Seeds. Operating income was up 9% to $90 million, with margin expanding 100 basis points to 18.7%. The garden business remains the seasonal anchor, and management noted strength as it enters the final phase of the garden season.

Guidance Hike Says More Than The Quarter

Central raised its fiscal 2026 non-GAAP diluted EPS guidance from $2.70 to $2.85 or better. That's a roughly 5.6% increase. The guidance excludes the pending TRIXIE acquisition and any further tariff refunds, which means the uplift reflects internal operational confidence: better margins, cost discipline, and a garden season that's tracking well.

The non-GAAP EPS for the quarter was $1.54, just $0.02 below the prior-year $1.56. CFO Brad Smith attributed the small decline to corporate spending on the TRIXIE transaction and data investments - costs that account for more than 100% of the operating income decline. Strip those out and earnings are essentially flat on higher-quality sales. That's the kind of quarter that warrants a guidance raise.

The TRIXIE Deal And What It Adds

The bigger story is the 80% stake Central agreed to buy in TRIXIE, Europe's leading pet supplies and snacks company, for up to €400 million (€340 million in cash plus a €60 million earn-out, where the earn-out is a contingent payment that depends on post-acquisition performance). TRIXIE was founded in 1974, operates out of Germany, employs nearly 600 people, and sells more than 6,000 products across 30,000 pet retail stores in Europe. Approximately 90% of its sales come from its own-brand portfolio, and it launches around 500 new products per year.

The deal gives Central an international footprint it didn't really have before. Management cited approximately 10% of net sales from outside the U.S. post-acquisition. The European pet supplies and snacks market is roughly €10 billion annually and growing at mid-single digits, driven by pet humanization, premiumization, and health trends. Central plans to layer its sourcing scale and product development onto TRIXIE's channel relationships and logistics infrastructure.

The acquisition is expected to close in the first half of fiscal 2027. TRIXIE's existing management team stays in place, and key shareholders retain a minority interest, which reduces integration risk. The €400 million price tag is material against a $2.7 billion market cap, but the cash on hand - $997 million at quarter end - and the cash-flow engine make it executable without excessive leverage.

Valuation Still Has Room

Central trades at 15.7 times trailing earnings and 11.7 times forward earnings, with an EV/EBITDA multiple of 9.4x and a PEG ratio (price-to-earnings divided by earnings growth rate, where lower values suggest better value relative to growth) of 0.34. The stock has rallied 37% year-to-date and sits near its 52-week high of $45.78, but the valuation hasn't run away from the fundamentals.

A PEG of 0.34 means the market is pricing the stock at less than one-third of its earnings growth rate. That is a deep discount for a company that just proved it can expand margins structurally, raised guidance on stronger cash flow, and has a clear growth platform in front of it through TRIXIE. Even if you discount the TRIXIE upside entirely and treat it as execution risk, the organic margin expansion alone supports a re-rating toward the mid-teens on forward multiples.

Free cash flow over the trailing twelve months stands at $282 million, or an FCF margin of 8.9%. That's solid for a consumer goods operator and gives the company plenty of dry powder for the TRIXIE acquisition, share repurchases, or further bolt-on deals in pet and garden.

Risks

• TRIXIE integration is the biggest near-term variable. Cross-border M&A in consumer goods carries execution risk, especially when the target operates across multiple European markets with different retail landscapes, regulations, and currencies. The €60 million earn-out means part of the price depends on post-close performance.
• Organic growth of 2% is thin. The margin story is compelling, but margin expansion has a ceiling. If branded pet and garden sales don't reaccelerate beyond low-single-digit growth, the multiple won't expand much further.
• The garden business is seasonal and weather-dependent. A weak 2027 garden season could pressure Q3 and Q4 results. The company is entering the final phase of the current season, but future quarters carry climate risk.
• Tariff exposure remains a wildcard. The guidance raise excludes potential further tariff refunds, implying tariff headwinds have already touched the business. If trade policy tightens, input costs for imported pet products could compress margins again.

The Verdict

Central Garden & Pet executed a clean surgery - cutting out the low-margin distribution business, expanding margins across both segments, and raising earnings guidance on record cash flow. The TRIXIE acquisition is a bet on international growth that the balance sheet can afford. The stock trades at a forward P/E of 11.7x and a PEG of 0.34, which is too cheap for a company with this margin trajectory and cash generation.

Rating: Buy. The key proof point to watch is whether organic growth in the pet segment accelerates beyond 2% as the margin benefits from the distribution exit fully flow through, and whether TRIXIE integration stays on track for a first-half fiscal 2027 close.